Ireland: Funds Quarterly Legal And Regulatory Update - 1 April 2015 To 30 June 2015


(i) ESMA opinion on the impact of EMIR on UCITS

Directive 2009/65/EC (the "UCITS Directive") requires UCITS investing in over-the-counter ("OTC") derivative transaction to adhere to counterparty exposure limits (in general 5% of net asset or 10% of net asset when the counterparty is a credit institution). Regulation 648/2012 on OTC derivatives, central counterparties ("CCPs") and trade repositories ("TR") (the "EMIR Regulations"), which was issued subsequent to the UCITS Directive, requires certain OTC derivative transactions be subject to clearing obligations. The question therefore arose as to how the EMIR Regulations would interact with the UCITS Directive? In particular, how the counterparty exposure limits for OTC derivative transactions which are centrally cleared (in accordance with the EMIR Regulations) should be calculated for the purpose of the UCITS Directive? On 22 July 2014, as a first step to addressing this matter, the European Securities and Markets Authority ("ESMA") issued a discussion paper (ESMA/2014/876) entitled, "Calculation of counterparty risk by UCITS for OTC financial Derivative transactions subject to clearing obligation" (the "Discussion Paper").

Following on from its Discussion Paper, on 22 May 2015 ESMA issued its Feedback Statement and Opinion (2015/ESMA/880) (the "Opinion"). In the Opinion, ESMA confirms that in its view, there is a conflict between the operation of the EMIR Regulations and the requirements of the UCITS Directive in relation to OTC financial derivative transactions. ESMA's Opinion therefore recommends that the UCITS Directive be amended to take account of the clearing obligations for certain types of OTC transactions required by the EMIR Regulations. ESMA submitted the opinion to the European Commission, European Council and European Parliament.

ESMA suggest that the UCITS Directive should no longer distinguish between OTC derivatives and Exchange Traded Derivatives ("ETDs"). Instead, ESMA is of the view that a distinction should be drawn between cleared and non-cleared derivatives/transactions.

As a result, the counterparty limits imposed by Article 51 of the UCITS Directive would apply to both ETDs and cleared OTC derivatives. At present only investments in OTC derivatives are subject to counterparty risk exposure limits under the UCITS Directive. However, different counterparty exposure limits would apply depending on the circumstances as outlined below.

For non-cleared derivative transactions (i.e. non-cleared OTC transactions), ESMA recommends that the existing 5/10% counterparty exposure limits should remain in place.

In respect of cleared derivative transactions, ESMA suggests that different counterparty exposure limits should be applied.

ESMA suggest that EU CCPs and Non-EU CCPs which are recognised by ESMA should be deemed to have a low risk.

Consequently, a UCITS should be permitted to have a high exposure limit to such CCPs. The Opinion does not clarify what "high limit" means in terms of an actual quantitative exposure limit.

In contrast, ESMA suggests that counterparty exposure limits to Non-EU CCPs which are not recognised by ESMA should be deemed to be higher risk. Consequently, the exposure limit of a UCITS to such CCPs should be lower (again, the Opinion provides no clarification what "lower" would mean in terms of an actual quantitative limit).

EMSA also indicates that in its view, separate counterparty exposure limits may need to be applied to CCPs and a CCP's clearing members.

The counterparty exposure limits to be applied by a UCITS to clearing members of EU CCPs and Non-EU CCPs recognised by ESMA should be determined based upon the type of account (i.e. individual client account or omnibus client account) which the UCITS has in place with the relevant CCP. In the case of an individual client account, it would not be necessary to have a separate (i.e. in addition to the exposure limit to the CCP) exposure limit to the clearing member. However, if the account is an omnibus client account, ESMA is of the view that a UCITS should be required to apply a counterparty exposure limit to the clearing member (in addition to the limit to the CCP). Again, the Opinion does not propose any particular limits in this regard.

Although ESMA has now issued an opinion on this matter calling for a modification of the UCITS Directive, it is still unclear as to when we may expect such modification to occur. This is because it would require an amendment to the Directive (which would have to go through the normal legislative process) and also because the Opinion itself is vague on the proposed levels of counterparty exposure which ESMA is suggesting would be appropriate to different circumstances (simply referring to high and low levels).

(ii) Central Bank Updates its Q&A on UCITS

On 12 June 2015, the Central Bank published a Fifth Edition of its UCITS Questions and Answers ("Q&A") document. The previous edition was published on 17 December 2014.

The aim of the UCITS Q&A is to outline answers to queries likely to arise in relation to UCITS. It is published in order to assist in limiting uncertainty. It is not relevant to assessing compliance with regulatory requirements.

The latest update sees the addition of a new question (Question ID 1013) which deals with Re-domiciliations:


Can an investment fund which re-domiciles to Ireland as a UCITS be permitted to disclose its past performance in its Key Investor Information Document ("KIID") relating to the period when it was domiciled outside Ireland?


The Central Bank will permit this past performance to be disclosed where the UCITS management company confirms that:

  • the UCITS investment policy, strategy and portfolio composition have not been substantially altered as a consequence of the transfer to the UCITS regime;
  • there is no change to the entities involved in the investment management of the UCITS;
  • it is satisfied that the past performance data is accurate; and
  • appropriate disclosure will be included with the past performance in the KIID stating that the data relates to a period when the investment fund was domiciled outside Ireland and was not authorised as a UCITS.

The updated Q&A is available via the following link:

(iii) EFAMA publish its latest Investment Funds Industry Fact Sheet

On 16 April 2015, the European Fund and Asset Management Association ("EFAMA") published its latest Investment Funds Industry Fact Sheet (the "Fact Sheet"), which provides net sales of UCITS and non-UCITS for April 2015.

Twenty-seven associations representing more than 99.6% of total UCITS and non-UCITS assets at the end of April 2015 provided net sales and/or net assets data. The main developments in April 2015 in the reporting countries can be summarised as follows:

  • Net sales of UCITS increased to €83 billion in April, up from €69 billion in March, as all fund categories attracted net new money during the month;
  • Long-term UCITS (UCITS excluding money market funds ("MMFs") continued to register large net inflows (€66 billion), albeit lower than in March (€71 billion);
  • Bond funds posted reduced net sales of €22 billion compared to €26 billion in March;
  • Equity funds experienced a turnaround in net flows to register inflows of €6 billion, against net outflows of €3 billion in March;
  • Balanced funds registered net inflows of €29 billion, down from €39 billion in March;
  • MMFs registered a turnaround in net sales in March to post net inflows of €16 billion, compared to net outflows of €2 billion in March;
  • Total non-UCITS net sales amounted to €16 billion, compared to €18 billion in March. Net sales of special funds (funds reserved to institutional investors) recorded a second consecutive month of net inflows of €12 billion; and
  • Total net assets of UCITS stood at €9,036 billion at the end April 2015, representing a 0.4 percent increase during the month. Total net assets of non-UCITS decreased 0.2 percent to stand at €3,541 billion at the month end. Overall, total net assets of the European investment fund industry stood at €12,577 billion at the end of April 2015.

Bernard Delbecque, Director of Economics and Research commented that "Demand for long-term UCITS remained robust in April as the economic outlook for Europe improved following the launch of quantitative easing by the ECB".

The fact sheet can be accessed via the following link:

(iv) UCITS V

In July 2012, the European Commission released a proposal on the revision of the UCITS regime in respect of depositary functions, remuneration policies and sanctions. Directive 2014/91/EU ("UCITS V") came into effect on September 17, 2014, and EU member states are required to transpose UCITS V into their national laws by March 18, 2016.

UCITS V is a further revision to the UCITS regime which aims to bring the UCITS regime into line in certain respects with the Alternative Investment Fund Management Directive ("AIFMD") and introduce a range of corresponding measures which had hitherto been regulated in somewhat less prescriptive terms.

The amendments to the existing UCITS regime aim to address lessons learned from the financial crises, most notably from the Madoff case which highlighted the lack of consistency in the application of the provisions of the UCITS Directive by Member States of the EU.

UCITS V focuses on three main areas namely:

  • UCITS depositary's eligibility, functions and liability in circumstances where assets are lost in custody;
  • rules governing remuneration policies which UCITS will be obliged to introduce; and
  • the harmonisation of the minimum administrative sanctions regime across EU Member States.

In terms of preparation for UCITS V, UCITS and UCITS management companies will need to consider how the forthcoming changes will impact upon their business. In particular such entities will need to consider how the changes will impact on each individual fund's current custody arrangements. In addition, it is likely that a review of the fund prospectus and related documentation, including the business plan, may also be required to take into account the new requirements.

In June 2015, Dillon Eustace published a guide to UCITS in Ireland, which is available via the following link:

(v) Proposed Central Bank UCITS Regulations

The Central Bank proposes publishing Central Bank UCITS Regulations which will consolidate, into one document, all of the conditions which the Central Bank imposes on UCITS, their management companies and depositaries.

It is expected that the Central Bank UCITS Regulations and Guidance Notes will be issued on a statutory basis and will replace the current UCITS Notices in the forthcoming months.

The Central Bank also proposes to eliminate the promoter approval process for UCITS in the same way as it has for alternative investment funds, to coincide with the new UCITS Regulations.

To read this Update in full, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions